Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Status:
Completed
Trial end date:
2017-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of solithromycin on hepatic histology
and biomarkers in patients with nonalcoholic steatohepatitis.